828 related articles for article (PubMed ID: 33647004)
1. Pitolisant (Wakix) for narcolepsy.
Med Lett Drugs Ther; 2021 Feb; 63(1617):19-21. PubMed ID: 33647004
[No Abstract] [Full Text] [Related]
2. Xywav - a mixed-salt oxybate oral solution for idiopathic hypersomnia.
Med Lett Drugs Ther; 2021 Dec; 63(1640):207-208. PubMed ID: 35100241
[No Abstract] [Full Text] [Related]
3. Solriamfetol (Sunosi) for excessive daytime sleepiness.
Med Lett Drugs Ther; 2019 Aug; 61(1579):132-134. PubMed ID: 31581157
[No Abstract] [Full Text] [Related]
4. Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepiness.
Inocente C; Arnulf I; Bastuji H; Thibault-Stoll A; Raoux A; Reimão R; Lin JS; Franco P
Clin Neuropharmacol; 2012; 35(2):55-60. PubMed ID: 22356925
[TBL] [Abstract][Full Text] [Related]
5. Pitolisant, a wake-promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol.
Krief S; Berrebi-Bertrand I; Nagmar I; Giret M; Belliard S; Perrin D; Uguen M; Robert P; Lecomte JM; Schwartz JC; Finance O; Ligneau X
Pharmacol Res Perspect; 2021 Oct; 9(5):e00855. PubMed ID: 34423920
[TBL] [Abstract][Full Text] [Related]
6. Pitolisant for treating patients with narcolepsy.
Li S; Yang J
Expert Rev Clin Pharmacol; 2020 Feb; 13(2):79-84. PubMed ID: 31937172
[No Abstract] [Full Text] [Related]
7. Pitolisant: First Global Approval.
Syed YY
Drugs; 2016 Sep; 76(13):1313-1318. PubMed ID: 27438291
[TBL] [Abstract][Full Text] [Related]
8. Emerging therapies in narcolepsy-cataplexy.
Mignot E; Nishino S
Sleep; 2005 Jun; 28(6):754-63. PubMed ID: 16477963
[TBL] [Abstract][Full Text] [Related]
9. The histamine H3 receptor: from discovery to clinical trials with pitolisant.
Schwartz JC
Br J Pharmacol; 2011 Jun; 163(4):713-21. PubMed ID: 21615387
[TBL] [Abstract][Full Text] [Related]
10. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial.
Dauvilliers Y; Bassetti C; Lammers GJ; Arnulf I; Mayer G; Rodenbeck A; Lehert P; Ding CL; Lecomte JM; Schwartz JC;
Lancet Neurol; 2013 Nov; 12(11):1068-75. PubMed ID: 24107292
[TBL] [Abstract][Full Text] [Related]
11. Role of the Histamine H
Schlicker E; Kathmann M
Handb Exp Pharmacol; 2017; 241():277-299. PubMed ID: 27787717
[TBL] [Abstract][Full Text] [Related]
12. Insomnia: chasing the dream.
Crow JM
Nature; 2013 May; 497(7450):S16-8. PubMed ID: 23698503
[No Abstract] [Full Text] [Related]
13. Preclinical evaluation of the abuse potential of Pitolisant, a histamine H₃ receptor inverse agonist/antagonist compared with Modafinil.
Uguen M; Perrin D; Belliard S; Ligneau X; Beardsley PM; Lecomte JM; Schwartz JC
Br J Pharmacol; 2013 Jun; 169(3):632-44. PubMed ID: 23472741
[TBL] [Abstract][Full Text] [Related]
14. [Pitolisant for the treatment of narcolepsy with or without cataplexy].
Bruhn C
Med Monatsschr Pharm; 2016 Aug; 39(8):324-9. PubMed ID: 29984945
[TBL] [Abstract][Full Text] [Related]
15. The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use.
Kollb-Sielecka M; Demolis P; Emmerich J; Markey G; Salmonson T; Haas M
Sleep Med; 2017 May; 33():125-129. PubMed ID: 28449891
[TBL] [Abstract][Full Text] [Related]
16. Pitolisant: A Review in Narcolepsy with or without Cataplexy.
Lamb YN
CNS Drugs; 2020 Feb; 34(2):207-218. PubMed ID: 31997137
[TBL] [Abstract][Full Text] [Related]
17. Antihistamine agents and pitolisant might be useful for anorexia nervosa.
Scolnick B
Med Hypotheses; 2019 Nov; 132():109342. PubMed ID: 31421416
[TBL] [Abstract][Full Text] [Related]
18. ▼Pitolisant for narcolepsy.
Drug Ther Bull; 2017 Jan; 55(1):6-8. PubMed ID: 28087755
[TBL] [Abstract][Full Text] [Related]
19. Multiple treatment comparison in narcolepsy: a network meta-analysis.
Lehert P; Falissard B
Sleep; 2018 Dec; 41(12):. PubMed ID: 30239930
[TBL] [Abstract][Full Text] [Related]
20. Pitolisant: Pediatric First Approval.
Keam SJ
Paediatr Drugs; 2023 Jul; 25(4):483-488. PubMed ID: 37233887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
